NEW YORK, Jan. 25 (GenomeWeb News) - The National Institutes of Health has awarded a five-year, $10 million grant to the University of California, San Francisco and SRI International to study the pharmacogenetics of nicotine addiction and treatment, SRI announced today.
SRI also announced the formation of a new molecular genetics program to analyze genetic predispositions to addiction and susceptibility for certain cancers.
The long-term research objectives of the program are to "better individualize treatment for tobacco dependence, facilitate the development of novel medications, and reduce the impact of smoking as a major health problem," the organization said in a statement.
Principal investigators for the program are Huijun Ring of SRI and Neil Benowitz of UCSF.